Lifeboat Foundation

A team of materials scientists and engineers from Donghua University, in China, and the National University of Singapore, has developed a type of fiber that does not rely on chips or batteries to convert visual signals to digital transmissions as it interacts with the human body.

The paper is published in the journal Science. Yunzhu Li and Yiyue Luo with the University of Illinois Urbana-Champaign and MIT, respectively, have published a Perspective piece in the same journal issue outlining the work done by the team on this new effort.

Over the past several years, scientists have been trying to find a way to integrate electronic devices with textiles for such applications as clothes that can display colors, patterns or even messages. Unfortunately, previous efforts involve adding stiff batteries and chips to materials, making them too uncomfortable to wear. In this new effort, the researchers have found a way to get around these problems.

It watches, saps the very spirit. And the worst thing of all is I watch it. I can’t not look. It’s like a drug, a horrible drug. You can’t resist it. It’s an addiction. These words of testimony are babbled by the crumbling Colonel Grover to describe O.B.I.T. — The Outer Band Individuated Teletracer — a hellishly precise surveillance machine of questionable origin. Uncovered by a murder investigation at a Defense Department research center, O.B.I.T. proves to be an insidious instrument that breeds fear and hostility. Both cautionary tale and tight courtroom drama, this haunting episode explores the fear and hostility that result when all privacy is eliminated…and all secrets are revealed! Alan Baxter, Jeff Corey and Peter Breck star!

Using electromagnetic fields or implanted medical devices to stimulate the brain can have benefits, but also carries risks. Computer simulations that reflect the unique complexity of each patient can help predict and solve problems before they arise.

Regenerating damaged tissues or organs has been a dream of scientists for decades. Now, researchers at the FMI and Novartis Biomedical Research have discovered a new molecule that activates a protein involved in regeneration. The tool holds promise for advancing our understanding of how organisms repair damaged tissue.

People with advanced neuroendocrine tumors in the digestive system may benefit from a treatment combination that includes the drug Lu 177-dotatate (Lutathera), according to the results of a first-of-its-kind clinical trial.

All participants in the trial, called NETTER-2, had advanced neuroendocrine tumors in the gastrointestinal tract or pancreas that had not yet been treated.

Those who received Lu 177-dotatate plus octreotide (Sandostatin) lived almost three times as long without their cancer getting worse (progression-free survival) as those who received octreotide alone—a median of nearly 23 months, versus 8.5 months. And the number of people whose tumors shrank, sometimes completely, was nearly five times greater in those who received both drugs compared to those who only received octreotide.

Post-mitotic neurons in the brain that re-enter the cell cycle quickly succumb to senescence, and this re-entry is more common in Alzheimer’s disease, according to a new study published April 9 in the open-access journal PLOS Biology by Kim Hai-Man Chow and colleagues at the Chinese University of Hong Kong.

The phenomenon may provide an opportunity to learn more about the neurodegeneration process, and the technique used to make this discovery is readily applicable to other inquiries about unique populations of cells in the brain.

Most neurons in the brain are post-mitotic, meaning they have ceased to divide. For many years, it had been assumed that this post-mitotic state was permanent. Recent discoveries have shown that a small proportion of neurons re-enter the cell cycle, but little is known about their fate after they do.

The researchers said the current design of the FRS means multiple cardiovascular conditions are overlooked and consequently under-diagnosed in women.

“When it comes to cardiovascular diseases in particular, the prevalence of these diseases is higher in men than women, but several studies have shown that women are less likely to be diagnosed during a routine exam, get diagnosed at an older age, and with more severe symptoms than men,” Skyler St. Pierre, a study author and a researcher at the Stanford University Living Matter Lab in California, told Medical News Today. “This really points to the fact that we are under-diagnosing women and the current screening methods are not catching women with cardiovascular diseases early enough.”

Thsi is a year old. But at 27 minutes David gets asked a couple fo “when” questions.

Dr. David Sinclair presents the progress of epigenetic reprogramming and rejuvenation in this video. He’s also answering questions on when he thinks the rejuvenation therapy be available in the Q\&A session at the end of the presentation.

Continue reading “Will Rejuvenation Therapy Be Available In Our LIFETIME? Gene Therapy VS Small Molecules” »

Years ago, a man paralyzed in a surfing accident was able to walk again after undergoing a revolutionary stem cell treatment. Now, he says that his mobility has only continued to improve! Chris Barr was one out of only 10 people to undergo this experimental treatment in a study by the Mayo Clinic. It’s safe to say that the procedure was a success for this patient!

“I never dreamed I would have a recovery like this,” Chris said, according to Good Morning America.

Continue reading “Man Who Was Paralyzed From The Neck Down Can Walk Again Thanks To Miracle Treatment” »